Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$848M |
| 2 |
Tesla
TSLA
|
+$759M |
| 3 |
Home Depot
HD
|
+$653M |
| 4 |
Meta Platforms (Facebook)
META
|
+$567M |
| 5 |
Wells Fargo
WFC
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$409M |
| 3 |
Micron Technology
MU
|
+$379M |
| 4 |
AT&T
T
|
+$372M |
| 5 |
Medtronic
MDT
|
+$370M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.03% |
| 2 | Technology | 14.98% |
| 3 | Consumer Discretionary | 11.43% |
| 4 | Consumer Staples | 10.71% |
| 5 | Communication Services | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACOR
2651
DELISTED
Acorda Therapeutics
ACOR
| $1.14M | ﹤0.01% |
35,361
-347
| -1% | -$13.6K |
|
2652
iShares Emerging Markets Dividend ETF
DVYE
$1.21B
| $1.14M | ﹤0.01% |
+34,800
| New | +$1.27M |
|
|
RNWK
2653
DELISTED
RealNetworks Inc
RNWK
| $1.14M | ﹤0.01% |
1,960,462
+2,204
| +0.1% | +$1.61K |
|
2654
Invesco Variable Rate Preferred ETF
VRP
$3.01B
| $1.14M | ﹤0.01% |
46,500
+21,944
| +89% | +$547K |
|
|
BBBY
2655
Bed Bath & Beyond
BBBY
$415M
| $1.14M | ﹤0.01% |
28,380
-330,330
| -92% | -$14.7M |
|
|
PVLA
2656
Palvella Therapeutics
PVLA
$2.25B
| $1.14M | ﹤0.01% |
4,682
+338
| +8% | +$88.8K |
|
|
ZY
2657
DELISTED
Zymergen Inc. Common Stock
ZY
| $1.14M | ﹤0.01% |
392,567
+308,139
| +365% | +$1.31M |
|
2658
Westwater Resources
WWR
$72.7M
| $1.13M | ﹤0.01% |
566,300
-478,269
| -46% | -$969K |
|
2659
Lamb Weston
LW
$7.3B
| $1.13M | ﹤0.01% |
18,900
-45,700
| -71% | -$2.84M |
|
2660
CVRx
CVRX
$82.1M
| $1.13M | ﹤0.01% |
188,500
+164,499
| +685% | +$1.33M |
|
2661
BBVA Argentina
BBAR
$3.13B
| $1.13M | ﹤0.01% |
317,588
+222,368
| +234% | +$724K |
|
2662
Castle Biosciences
CSTL
$905M
| $1.12M | ﹤0.01% |
25,000
-109,281
| -81% | -$4.52M |
|
|
GPL
2663
DELISTED
Great Panther Mining Limited
GPL
| $1.12M | ﹤0.01% |
446,153
+107,001
| +32% | +$255K |
|
2664
South Plains Financial
SPFI
$858M
| $1.12M | ﹤0.01% |
42,100
-20,200
| -32% | -$572K |
|
|
LUNA
2665
DELISTED
Luna Innovations Incorporated
LUNA
| $1.12M | ﹤0.01% |
144,901
+15,500
| +12% | +$111K |
|
2666
Barnes & Noble Education
BNED
$421M
| $1.11M | ﹤0.01% |
3,113
+2,223
| +250% | +$1.19M |
|
2667
Churchill Downs
CHDN
$6.33B
| $1.11M | ﹤0.01% |
10,050
-124,000
| -93% | -$13.6M |
|
|
SKE
2668
Skeena Resources
SKE
$4.1B
| $1.11M | ﹤0.01% |
99,950
+73,600
| +279% | +$828K |
|
2669
Peoples Bancorp of North Carolina
PEBK
$239M
| $1.11M | ﹤0.01% |
38,792
-1,100
| -3% | -$31.2K |
|
|
SUNL
2670
DELISTED
Sunlight Financial Holdings, Inc.
SUNL
| $1.1M | ﹤0.01% |
10,895
+6,610
| +154% | +$512K |
|
|
LOAN
2671
Manhattan Bridge Capital
LOAN
$47.1M
| $1.09M | ﹤0.01% |
172,218
+2,345
| +1% | +$13.6K |
|
2672
Nordic American Tanker
NAT
$1.42B
| $1.09M | ﹤0.01% |
+513,800
| New | +$912K |
|
|
PPLT
2673
abrdn Physical Platinum Shares ETF
PPLT
$2.04B
| $1.09M | ﹤0.01% |
+119,000
| New | +$1.14M |
|
|
INFI
2674
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $1.09M | ﹤0.01% |
957,460
+591,065
| +161% | +$706K |
|
2675
Lisata Therapeutics
LSTA
$9.82M
| $1.09M | ﹤0.01% |
100,490
-6,220
| -6% | -$71.2K |
|
Similar funds
Jim Simons's Q1 2022 Portfolio in Review
As of Q1 2022, Jim Simons held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons deployed $8.98B of net new capital in Q1 2022, opening 822 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.
- Jim Simons's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
- Jim Simons added most to Tesla in Q1 2022, an estimated $759M increase.
- Jim Simons's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
- Jim Simons fully exited Microsoft in Q1 2022, selling an estimated $786M.
- Jim Simons's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
- Jim Simons opened 822 new positions and closed 650 in Q1 2022.
- Jim Simons's portfolio value rose 6% quarter-over-quarter to $85.2B.
Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.